Analysis of current status of neoadjuvant chemotherapy for non-small cell lung cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 109-112, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-743100
ABSTRACT
Lung cancer has been the most dangerous malignant tumor in the worldwide.Nowadays,for patients with resectable early or local advanced non-small cell lung cancer (NSCLC),both domestic and foreign guidelines recommended multidisciplinary treatments like surgery,chemotherapy and radiotherapy.Recent studies have shown that neoadjuvant chemotherapy can significantly improve the prognosis of patients with resectable NSCLC and has better treatment compliance and tolerance.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Practice guideline
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS